用于癌症免疫治疗的单克隆抗体
Louis M Weiner1, Madhav V Dhodapkar, Soldano Ferrone
1Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Lancet (London, England)
|March 24, 2009
概括
单克隆抗体可以被设计成刺激免疫系统对抗癌症. 这种方法增强了抗瘤免疫反应,可能改善癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 单克隆抗体是已知的癌症治疗药物.
- 它们在启动瘤特异性免疫反应中的作用尚未得到充分研究.
- 了解这些免疫机制对于推进抗体治疗至关重要.
研究的目的:
- 为开发刺激宿主抗瘤免疫反应的抗体提供理由和证据.
- 探索抗体可以增强抗癌免疫力的机制.
- 为突出优化基于抗体的癌症免疫疗法的未来方向.
主要方法:
- 关于癌症抗体机制的现有文献的综述.
- 对抗体依赖细胞细胞毒性 (ADCC) 的分析.
- 对抗体向抗原交叉呈现的评估.
- 考虑白痴类型的网络交互.
主要成果:
- 抗体可以通过ADCC诱导抗瘤免疫.
- 抗体可以促进瘤抗原与T细胞的交叉呈现.
- 型网络为免疫刺激提供了另一条途径.
- 这些机制为新的免疫治疗策略提供了基础.
结论:
- 抗体治疗可以通过利用瘤抗原特异性免疫反应来增强.
- 未来的策略应该专注于延长,放大和塑造这些免疫反应.
- 优化抗体治疗有望改善人类癌症的临床结果.
相关概念视频
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...